These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 9709770)
21. The effect of topical timolol on epinephrine-stimulated aqueous humor flow in sleeping humans. Rettig ES; Larsson LI; Brubaker RF Invest Ophthalmol Vis Sci; 1994 Feb; 35(2):554-9. PubMed ID: 8113006 [TBL] [Abstract][Full Text] [Related]
22. Intravenous epinephrine stimulates aqueous formation in the human eye. Kacere RD; Dolan JW; Brubaker RF Invest Ophthalmol Vis Sci; 1992 Sep; 33(10):2861-5. PubMed ID: 1526735 [TBL] [Abstract][Full Text] [Related]
23. Aqueous humor flow in sleeping humans is unaffected by norepinephrine infusion. Vanlandingham BD; FitzSimon JS; Brubaker RF Invest Ophthalmol Vis Sci; 1998 Aug; 39(9):1759-62. PubMed ID: 9699568 [TBL] [Abstract][Full Text] [Related]
24. Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs. Gelatt KN; MacKay EO Vet Ophthalmol; 2001 Mar; 4(1):61-7. PubMed ID: 11397321 [TBL] [Abstract][Full Text] [Related]
25. A randomized study of dorzolamide in the prevention of elevated intraocular pressure after anterior segment laser surgery. Dorzolamide Laser Study Group. Hartenbaum D; Wilson H; Maloney S; Vacarelli L; Orillac R; Sharpe E J Glaucoma; 1999 Aug; 8(4):273-5. PubMed ID: 10464738 [TBL] [Abstract][Full Text] [Related]
26. A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide. Clineschmidt CM; Williams RD; Snyder E; Adamsons IA Ophthalmology; 1999 Dec; 106(12 Suppl):17-24. PubMed ID: 10598693 [TBL] [Abstract][Full Text] [Related]
27. [The hypotensive action and side effects of the carboanhydrase inhibitor dorzolamide hydrochloride]. Egorov AE Vestn Oftalmol; 1996; 112(2):3-4. PubMed ID: 9045485 [TBL] [Abstract][Full Text] [Related]
28. The efficacy and safety of dorzolamide as adjunctive therapy to timolol maleate gellan solution in patients with elevated intraocular pressure. Additivity Study Group. Adamsons I; Clineschmidt C; Polis A; Taylor J; Shedden A; Laibovitz R J Glaucoma; 1998 Aug; 7(4):253-60. PubMed ID: 9713783 [TBL] [Abstract][Full Text] [Related]
29. Effects of dorzolamide on choroidal blood flow, ciliary blood flow, and aqueous production in rabbits. Reitsamer HA; Bogner B; Tockner B; Kiel JW Invest Ophthalmol Vis Sci; 2009 May; 50(5):2301-7. PubMed ID: 19182250 [TBL] [Abstract][Full Text] [Related]
30. Studies on the mechanism of action of timolol and on the effects of suppression and redirection of aqueous flow on outflow facility. Kiland JA; Gabelt BT; Kaufman PL Exp Eye Res; 2004 Mar; 78(3):639-51. PubMed ID: 15106944 [TBL] [Abstract][Full Text] [Related]
31. [Effect of topical carbonic anhydrase inhibitor (MK-507) on intraocular pressure of normal human eyes]. Yamazaki Y; Miyamoto S; Sawa M Nippon Ganka Gakkai Zasshi; 1994 Mar; 98(3):293-7. PubMed ID: 8154389 [TBL] [Abstract][Full Text] [Related]
32. MK-507 (L-671,152), a topically active carbonic anhydrase inhibitor, reduces aqueous humor production in monkeys. Wang RF; Serle JB; Podos SM; Sugrue MF Arch Ophthalmol; 1991 Sep; 109(9):1297-9. PubMed ID: 1929960 [TBL] [Abstract][Full Text] [Related]
33. Effect of thymoxamine on aqueous humor formation in the normal human eye as measured by fluorophotometry. Lee DA; Brubaker RF; Nagataki S Invest Ophthalmol Vis Sci; 1981 Dec; 21(6):805-11. PubMed ID: 6458577 [TBL] [Abstract][Full Text] [Related]
34. Effects of dorzolamide hydrochloride 2% on the retinal circulation. Grunwald JE; Mathur S; DuPont J Acta Ophthalmol Scand; 1997 Jun; 75(3):236-8. PubMed ID: 9253964 [TBL] [Abstract][Full Text] [Related]
35. Population pharmacokinetics of 2% topical dorzolamide in the aqueous humor of humans. Schmitz K; Banditt P; Motschmann M; Meyer FP; Behrens-Baumann W Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1621-4. PubMed ID: 10359348 [TBL] [Abstract][Full Text] [Related]
36. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Strohmaier K; Snyder E; DuBiner H; Adamsons I Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691 [TBL] [Abstract][Full Text] [Related]
37. Methazolamide 1% in cyclodextrin solution lowers IOP in human ocular hypertension. Gudmundsdóttir E; Stefánsson E; Bjarnadóttir G; Sigurjónsdóttir JF; Gudmundsdóttir G; Masson M; Loftsson T Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3552-4. PubMed ID: 11006251 [TBL] [Abstract][Full Text] [Related]
38. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study. Martínez A; Sánchez M Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468 [TBL] [Abstract][Full Text] [Related]
39. The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor. Sugrue MF J Ocul Pharmacol Ther; 1996; 12(3):363-76. PubMed ID: 8875343 [TBL] [Abstract][Full Text] [Related]
40. Effects of topical 2% dorzolamide hydrochloride alone and in combination with 0.5% timolol maleate on intraocular pressure in normal feline eyes. Dietrich UM; Chandler MJ; Cooper T; Vidyashankar A; Chen G Vet Ophthalmol; 2007; 10 Suppl 1():95-100. PubMed ID: 17973840 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]